Toxic shock syndrome diagnostic criteria: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(6 intermediate revisions by 3 users not shown)
Line 4: Line 4:


== Overview ==
== Overview ==
Diagnosis of [[Toxic shock syndrome|Toxic Shock Syndrome]] (TSS) is mainly based on the clinical presentation include [[fever]] >38.9°C, [[hypotension]], diffuse [[erythroderma]], [[desquamation]].  
Diagnosis of [[Toxic shock syndrome|Toxic Shock Syndrome]] (TSS) is mainly based on the clinical presentation including [[fever]] >38.9°C, [[hypotension]], diffuse [[erythroderma]], [[desquamation]].  
==Diagnostic Criteria==
==Diagnostic Criteria==
=== Toxic Shock Syndrome (Other Than Streptococcal) (TSS) ===
=== Toxic Shock Syndrome (Other Than Streptococcal) (TSS) ===
Line 21: Line 21:
*** [[Diarrhea]] at onset of [[illness]] (especially watery)
*** [[Diarrhea]] at onset of [[illness]] (especially watery)
** [[Muscular]]:
** [[Muscular]]:
*** Severe myalgia
*** Severe [[myalgia]]
*** Increased creatine phosphokinase (CPK) level at least twice the upper limit of normal
*** Increased [[creatine phosphokinase]] ([[CPK]]) level at least twice the upper limit of normal
** [[Mucous membrane]] [[Conjunctival disease|inflammation]]:  
** [[Mucous membrane]] [[Conjunctival disease|inflammation]]:  
***[[Vaginal]]
***[[Vaginal]]
Line 30: Line 30:
*** [[Blood urea nitrogen]] or [[creatinine]] at least twice the upper limit of normal.
*** [[Blood urea nitrogen]] or [[creatinine]] at least twice the upper limit of normal.
*** Urinary sediment with [[pyuria]] (greater than or equal to 5 [[leukocytes]] per high-power field) in the absence of [[urinary tract infection]]
*** Urinary sediment with [[pyuria]] (greater than or equal to 5 [[leukocytes]] per high-power field) in the absence of [[urinary tract infection]]
** [[Hepatic]]: Increase of the hepatic enzymes twice the upper limit of normal for laboratory:
** [[Hepatic]]: Increase of the hepatic enzymes twice the upper limit of normal.
*** [[Bilirubin|Total bilirubin]]
*** [[Bilirubin|Total bilirubin]]
*** [[Alanine aminotransferase|Alanine]] [[aminotransferase]]
*** [[Alanine aminotransferase|Alanine]] [[aminotransferase]]
*** [[Aspartate|Aspartate aminotransferase]]
*** [[Aspartate|Aspartate aminotransferase]]
** [[Hematologic]]: [[Platelets]] less than 100,000/mm3
** [[Hematologic]]:  
*** [[Platelets]] less than 100,000/mm3
** [[Central nervous system]]:  
** [[Central nervous system]]:  
*** [[Disorientation]] or alterations in [[consciousness]] without [[focal neurologic signs]] when [[fever]] and [[hypotension]] are absent.<ref name="pmid2294395"><nowiki>cite journal |vauthors= |title=Repeat injuries in an inner city population--Philadelphia, 1987-1988 |journal=MMWR Morb. Mortal. Wkly. Rep. |volume=39 |issue=1 |pages=1–3 |year=1990 |pmid=2294395 |doi= |url=}}</nowiki></ref><ref name="pmid9148133">{{cite journal |vauthors= |title=Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention |journal=MMWR Recomm Rep |volume=46 |issue=RR-10 |pages=1–55 |year=1997 |pmid=9148133 |doi= |url=}}</ref>
*** [[Disorientation]] or alterations in [[consciousness]] without [[focal neurologic signs]].<ref name="pmid2294395"><nowiki>cite journal |vauthors= |title=Repeat injuries in an inner city population--Philadelphia, 1987-1988 |journal=MMWR Morb. Mortal. Wkly. Rep. |volume=39 |issue=1 |pages=1–3 |year=1990 |pmid=2294395 |doi= |url=}}</nowiki></ref><ref name="pmid9148133">{{cite journal |vauthors= |title=Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention |journal=MMWR Recomm Rep |volume=46 |issue=RR-10 |pages=1–55 |year=1997 |pmid=9148133 |doi= |url=}}</ref>


==== Laboratory Criteria for Diagnosis ====
==== Laboratory Criteria for Diagnosis ====
Line 49: Line 50:
=== Streptococcal TSS ===
=== Streptococcal TSS ===
There is a subtle difference between [[Streptococcus|Streptococcal]] TSS and other types. [[Streptococcus|Group A Streptococcus(GAS]]) can be isolated in GAS-related TSS patients.
There is a subtle difference between [[Streptococcus|Streptococcal]] TSS and other types. [[Streptococcus|Group A Streptococcus(GAS]]) can be isolated in GAS-related TSS patients.
* Clinical and biochemical criteria of [[Streptococcus|streptococcal]] TSS and [[necrotizing fasciitis]] (NF).<ref name="urlwwwnc.cdc.gov">{{cite web |url=https://wwwnc.cdc.gov/eid/article/1/3/pdfs/95-0301.pdf |title=wwwnc.cdc.gov |format= |work= |accessdate=}}</ref>
====Clinical and biochemical criteria of [[Streptococcus|streptococcal]] TSS and [[necrotizing fasciitis]] (NF).<ref name="urlwwwnc.cdc.gov">{{cite web |url=https://wwwnc.cdc.gov/eid/article/1/3/pdfs/95-0301.pdf |title=wwwnc.cdc.gov |format= |work= |accessdate=}}</ref>====
{| class="wikitable"
{| class="wikitable"
!Disease presentation
! align="center" style="background:#4479BA; color: #FFFFFF;" |Disease Presentation
! colspan="2" |Criteria
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Criteria
!Definite case
! align="center" style="background:#4479BA; color: #FFFFFF;" |Definite case
!Suspected case
! align="center" style="background:#4479BA; color: #FFFFFF;" |Suspected case
|-
|-
! rowspan="2" |Streptococal TSS
! rowspan="2" align="center" style="background:#DCDCDC;"|Streptococal TSS
|A. Isolation of group A [[Streptococcus]]
|A. Isolation of group A [[Streptococcus]]
|1. From a [[sterile]] site  
|1. From a [[sterile]] site  


2. From a nonsterile body site
2. From a nonsterile body site
| rowspan="2" |A1+B
| rowspan="2" |A1 '''+''' B(complete)
(B for total criteria)
 
| rowspan="2" |A2+B
| rowspan="2" |A2 '''+''' B(complete)
(B for total criteria)
 
|-
|-
|B. Clinical signs of severity
|B. Clinical signs of severity
Line 77: Line 78:
** [[Erythematous]] [[rash]]
** [[Erythematous]] [[rash]]
|-
|-
! rowspan="2" |Necrotizing fasciitis
! rowspan="2" align="center" style="background:#DCDCDC;"|Necrotizing fasciitis
|A. Clinical Criteria
|A. Clinical Criteria
|
|
Line 90: Line 91:
*** [[Hepatic failure|Liver failure]]
*** [[Hepatic failure|Liver failure]]
*** [[Renal failure]]
*** [[Renal failure]]
| rowspan="2" |A+B1
| rowspan="2" |A (complete) '''+''' B1
(A for total criteria)
 
| rowspan="2" |A+B2
| rowspan="2" |A (complete) '''+''' B2
A+B3
A(complete) '''+''' B3


(A for total criteria)
|-
|-
|B. Isolation of group A [[Streptococcus]]
|B. Isolation of group A [[Streptococcus]]
Line 113: Line 113:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Syndromes]]
[[Category:Syndromes]]
[[Category:Infectious disease]]
[[Category:Needs overview]]
[[Category:Needs overview]]
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Emergency mdicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]

Latest revision as of 00:26, 30 July 2020

Toxic shock syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Shock Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic shock syndrome diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic shock syndrome diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic shock syndrome diagnostic criteria

CDC on Toxic shock syndrome diagnostic criteria

Toxic shock syndrome diagnostic criteria in the news

Blogs on Toxic shock syndrome diagnostic criteria

Directions to Hospitals Treating Toxic shock syndrome

Risk calculators and risk factors for Toxic shock syndrome diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Overview

Diagnosis of Toxic Shock Syndrome (TSS) is mainly based on the clinical presentation including fever >38.9°C, hypotension, diffuse erythroderma, desquamation.

Diagnostic Criteria

Toxic Shock Syndrome (Other Than Streptococcal) (TSS)

Clinical Criteria

The diagnosis of Staphylococcal toxic shock syndrome (TSS) is based upon clinical presentation. An epidemiological clinical criteria list has been established by United States Centers for Disease Control and Prevention (CDC) for epidemiologic studies on Staphylococcal TSS. This criteria list is epidemiologicaly usable only, meaning that a patient can not be excluded from disease based on the absence of one of these criteria. This criteria list points that a confirmed case is someone who has fever >38.9°C, hypotension, diffuse erythroderma, desquamation (unless the patient dies before desquamation can occur), and involvement of at least three organ systems. If a patient misses one of these criteria, the case may be considered as a probable/susceptible case.[1]

TSS diagnosis can be made with the following clinical manifestations:

Laboratory Criteria for Diagnosis

If the result of the following tests become negative, it can be considered a positive criteria for TSS:

Streptococcal TSS

There is a subtle difference between Streptococcal TSS and other types. Group A Streptococcus(GAS) can be isolated in GAS-related TSS patients.

Clinical and biochemical criteria of streptococcal TSS and necrotizing fasciitis (NF).[5]

Disease Presentation Criteria Definite case Suspected case
Streptococal TSS A. Isolation of group A Streptococcus 1. From a sterile site

2. From a nonsterile body site

A1 + B(complete) A2 + B(complete)
B. Clinical signs of severity
Necrotizing fasciitis A. Clinical Criteria A (complete) + B1 A (complete) + B2

A(complete) + B3

B. Isolation of group A Streptococcus
  1. Isolation of group A Streptococcus from a normally sterile body sites
  2. Serologic confirmation of group A streptococcal infection by a 4-fold rise against:
a) streptolysin O b) DNase B
3. Histologic confirmation: Gram-positive cocci in a necrotic soft tissue infection

References

  1. Tofte RW, Williams DN (1981). "Toxic shock syndrome. Evidence of a broad clinical spectrum". JAMA. 246 (19): 2163–7. PMID 7289007.
  2. cite journal |vauthors= |title=Repeat injuries in an inner city population--Philadelphia, 1987-1988 |journal=MMWR Morb. Mortal. Wkly. Rep. |volume=39 |issue=1 |pages=1–3 |year=1990 |pmid=2294395 |doi= |url=}}
  3. "Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention". MMWR Recomm Rep. 46 (RR-10): 1–55. 1997. PMID 9148133.
  4. "Toxic Shock Syndrome (Other Than Streptococcal) | 2011 Case Definition".
  5. "wwwnc.cdc.gov" (PDF).


Template:WikiDoc Sources